The global microbiome sequencing services market is expected to register a CAGR of 18.0% during the forecast period, 2018 to 2023. North America dominates the market due to a surge in technological advancement in next-generation sequencing (NGS) projects in the region.
Huge Investment in Microbiome Research The sequencing of metagenome offers a novel method in diagnosing and treating a wide range of chronic diseases, such as oncology, etc. The metagenome differs from person to person significantly, which is key to its diagnostic potential, due to which the government is investing a large number of funds for microbiome sequencing projects. In 2007, the US National Institutes of Health (NIH) funded USD 140 million to the Human Microbiome Project, which examines all the microorganisms in the human body. In 2008, the European Commission financed USD 29 million for Metagenomics of the Human Intestinal Tract project (MetaHIT). The Wall Street Journal in 2016, reported that from 2011 to 2015, venture funding in microbiome firms climbed by 458.5% to USD114.5 million. About USD 616.9 million was raised for microbiome companies in 2016, which is more than all of the venture investment in the microbiome space between 2011 to 2015 period. Also, rising demand for NGS, surge in genomic research, and widening application area of microbiome sequencing, and a decline in the cost of sequencing are the major factors driving the growth of the market.
Lack of Skilled Technicians for NGS Data Analysis Lack of technicians in the interpretation of sequencing data is the major factor restricting the growth of the microbiome sequencing services market. Microbiome sequencing generates a huge amount of data, which needs to be interpreted using advanced software. The lack of awareness and knowledge of advanced tools of data analysis among physicians and scientists is the major factor restricting the growth of the global microbiome sequencing services market. Further, government regulations and ethical & legal issues related to NGS are the also restraining the growth of the microbiome sequencing services market.
North America to Dominate the Market The microbiome sequencing services market is segmented by technology type, application, end user, and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.
North America dominates the microbiome sequencing services market, owing to factors, such as government support through funds for genomics research, consistent developments in sequencing technologies, and ease in availability of commercial solutions for NGS data analysis. Asia-Pacific is also expected to grow tremendously during the forecast period, owing to growing number of research studies on cancer and inherited rare diseases, and rising demand for next-generation sequencing for diagnosis and therapeutic applications.
Key Developments in the Market November 2017: MicroBiome Therapeutics, LLC launched first microbiome modulator. The product is described as an all-natural blend of prebiotics, including fermentable fiber and polyphenol antioxidants, in a patent-pending blend intended to help nurture and nourish beneficial microorganisms in the lower gut. June 2017: Zymo Research Corp. launched new kits for Microbiome Research at ASM Microbe 2017. Major Players: Clinical Microbiomics A/S, Baseclear B.V., Metabiomics Corp., Microbiome Insights Inc., Microbiome Therapeutics, LLC., MR DNA, Merieux Nutrisciences Corporation, Ubiome, Inc., Zymo Research Corp., and Second Genome, among others
Reasons to Purchase this Report Current and future global microbiome sequencing services market outlook in the developed and emerging markets Analysis of various perspectives of the market with the help of Porter’s five forces analysis The segment that is expected to dominate the market Regions that are expected to witness the fastest growth during the forecast period Identify the latest developments, market shares, and strategies employed by the major market players 3 months analyst support, along with the Market Estimate sheet (in excel)
Customization of the Report This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Our reports have been used by over 10K customers, including:
Global High-throughput Satellite Market to Reach $7.31 Billion by 2023 The global high-throughput satellite market has exhibited a high growth in the recent past.Currently, the space industry is at the cusp of a major revolution, as a large number of HTS are expected to be launched in the next five years. The...
Global Next-generation Sequencing Market to Register a CAGR of 19.2% from 2018 to 2024 The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2%. Factors such as advancements in NGS platforms, declining NGS capital cost coupled with decreasing...
Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2018 Summary GlobalData’s Medical Devices sector report, “Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2018" provides an overview of Hepatitis Test Kits currently in pipeline stage. The report provides comprehensive information...
431 pages •
By Global Industry Analysts
• Jul 2018
This report analyzes the worldwide markets for Laboratory Chemical Reagents in US$ Thousand by the following Segments and Application Areas: Molecular Biology (Monoclonal & Polyclonal Antibodies, Gene Expression, Vectors, Cloning & Sequencing, Gene Synthesis, PCR Reagents, Enzymes, & Others), Biochemistry, Cytokine & Chemokine Testing,...
The transplant diagnostics market projected to grow at a CAGR of 7.4%. The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from USD 3.44 billion in 2018, at a CAGR of 7.4%. Increasing number of transplantation procedures, technological advancements in the field of transplant diagnostics, increasing public-private...